Articles

  • Jan 23, 2025 | scientificamerican.com | Marcy Thompson |Katie Hafner |Deborah Unger

    In honor of International Holocaust Remembrance Day next week, Lost Women of Science is telling the story of Margarethe Hilferding, a pioneering psychoanalyst and physician from Vienna who was murdered in a Nazi concentration camp in 1942. She was the first woman to earn a medical degree at the University of Vienna and the first woman to join Sigmund Freud’s Vienna Psychoanalytic Society.

  • Oct 10, 2024 | scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger

    It’s September 2024, and a group of American thalidomide survivors and their family members arrive in Washington, D.C., to lobby the government for support. More than 60 years have gone by since Food and Drug Administration medical examiner Frances Oldham Kelsey first stalled the new drug application for thalidomide from the pharmaceutical company Richardson-Merrell.

  • Oct 3, 2024 | scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger

    It’s the summer of 1962, and the drug thalidomide has been off the market in Europe for months after it was determined to be unsafe to use during pregnancy. But in the U.S., people are only just beginning to find out about the scandal. The Washington Post breaks the story and puts a picture of Food and Drug Administration medical examiner Frances Oldham Kelsey, who refused to approve the medication, on the front page. She’s the hero who saved American lives. President John F.

  • Sep 26, 2024 | scientificamerican.com | Katie Hafner |Elah Feder |Deborah Unger

    It’s the early 1960s, and Widukind Lenz, a German pediatrician, is going door to door in his efforts to find out what is causing an epidemic of babies born with shortened limbs and other serious medical conditions. In the U.S. the drug company Richardson-Merrell is battling with Frances Oldham Kelsey at the Food and Drug Administration about the pending approval of thalidomide. She’s asking for data that show it’s safe to use during pregnancy (spoiler alert: it’s not).

  • Sep 19, 2024 | scientificamerican.com | Katie Hafner |Sarah Wyman |Elah Feder

    It’s the early 1960s, and the German pharmaceutical market is booming. A sedative called Contergan is one of the best-selling drugs. Contergan’s active ingredient is thalidomide, and it is touted as a wonder drug, a nonaddictive sedative that is safer than barbiturates. In the U.S. the drug is called Kevadon, and its distributor is impatient to get it on the market.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
4K
Tweets
2K
DMs Open
Yes
Katie Hafner
Katie Hafner @katiehafner
23 Jan 25

A riveting, tragic, infuriating story. Congrats to Marcy Thompson, Deborah Unger, Adam Arnone, Lily Whear, and the rest of the Lost Women of Science team. @Marcys_projects @LostWomenofSci @ECHOFINCHLLC @DebWiseUnger https://t.co/HP5AFQH0gB

Katie Hafner
Katie Hafner @katiehafner
2 Jan 25

RT @TheFigen_: Beautiful moment toddler covers pregnant mother with blanket as she falls asleep on sofa. https://t.co/Cz1SL72jBG

Katie Hafner
Katie Hafner @katiehafner
30 Dec 24

Oh how I love this. https://t.co/07IuVSuCT2 Thank you, @SamWhitingSF @sfchronicle